Find SAMHSA-supported continuing medical education (CME) courses on prescribing opioids for chronic pain.
Each year, millions of patients are treated for a variety of serious medical conditions with prescription drugs whose therapeutic benefits can alter behavior, mood, and consciousness. This is particularly true of the management of chronic pain, which often involves potent opioid pain relievers. The misuse and abuse of prescription opioid pain relievers is on the rise. Physicians and other health care professionals thus face the challenge of minimizing the potential for misuse of these important medications without impeding patients’ access to needed medical care.
Many of the medications used in medication-assisted treatment (MAT) are controlled substances due to their potential for misuse. Teaching MAT professionals how to prescribe these medications will increase patient awareness of the safe use of MAT medications and improve their prospects for a full recovery.
SAMHSA funds continuing medical education (CME) courses on prescribing opioids for chronic pain developed by local and state health organizations across the United States. Most of these courses also include resources that address practice management, legal and regulatory issues, opioid pharmacology, and strategies for managing challenging patient situations.
The following are sponsors of SAMHSA-supported CME courses on prescribing opioids for chronic pain (courses may require registration):
- The American Academy of Addiction Psychiatry (AAAP) provides a number of CME opportunities for MAT professionals seeking training on prescribing opioids for chronic pain.
- The American Osteopathic Academy of Addiction Medicine (AOAAM) offers a number of SAMHSA-supported prescribing courses, including a self-study series developed by the Providers’ Clinical Support System for Medication Assisted Treatment (PCSS-MAT).
- The American Society for Pain Management Nursing (ASPMN) sponsors prescribing courses developed by the Providers’ Clinical Support System for Opioid Therapies (PCSS-O).
- The American Society of Addiction Medicine (ASAM) sponsors a number of prescribing courses for MAT services providers. ASAM’s education website offers more than 300 hours of CME learning through live and online instruction.
- Prescribe to Prevent at OpioidPrescribing.com
The Division of Pharmacologic Therapies (DPT), part of the SAMHSA Center for Substance Abuse Treatment (CSAT), also provides buprenorphine training for physicians.
In addition, the Addiction Technology Transfer Center (ATTC) Network (funded by SAMHSA) has a training and events calendar to help you stay abreast of future prescription courses.
Opioid Prescribing Course Inquiries
For more information about SAMHSA-supported opioid prescribing courses, contact the following SAMHSA representative by telephone, mail, or email:
The views expressed in these courses and related materials do not necessarily reflect the official policies of the Department of Health and Human Services (HHS); nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
SAMHSA-supported courses are planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint sponsorship with the host organizations and CSAT.